M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring

Short descriptor: Bamlanivimab-xxxx infusion

⚠ Terminated HCPCS Level II 2026
Terminated Code
M0239 was terminated as of 2021-04-16 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open M0239 in the app →

Look up M0239 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

M0239 is the HCPCS Level II code for Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring (2026). It belongs to Section M — Medical Services. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Vaccinations.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Vaccinations (indicator 54)
Type of Service
Pneumococcal/flu/hepatitis B vaccine
Effective Date
2021-04-17
Termination Date
2021-04-16
2026 Maintenance
No change this year

References

Cite This Page

Reference M0239 with the canonical source and edition:

M0239 — Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/M0239

Canonical URL: https://icd10codingpro.com/hcpcs-codes/M0239

Related Codes in Section M

← M0238 Intrav inf, toci, second dos M0240 → Casiri and imdev repeat
M0235 Intrav inf, mon anti, fir do M0236 Intrav inf, mon anti, sec do M0237 Intrav inf, toci, first dose M0238 Intrav inf, toci, second dos M0240 Casiri and imdev repeat M0241 Casiri and imdev repeat hm M0243 Casirivi and imdevi inj M0244 Casirivi and imdevi inj hm M0245 Bamlan and etesev infusion M0246 Bamlan and etesev infus home
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial